Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
199.5 PLN | -1.72% | -4.09% | +5.00% |
Jan. 18 | Creotech Instruments Sign Agreement with European Space Agency | CI |
2023 | Creotech Instruments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | 171.3 | 225.6 |
Enterprise Value (EV) 1 | 164.8 | 202.4 |
P/E ratio | 361 x | -32.1 x |
Yield | - | - |
Capitalization / Revenue | 5.18 x | 10.9 x |
EV / Revenue | 4.99 x | 9.77 x |
EV / EBITDA | 113 x | -49.3 x |
EV / FCF | -13,761,825 x | -12,903,298 x |
FCF Yield | -0% | -0% |
Price to Book | 9.41 x | 4.66 x |
Nbr of stocks (in thousands) | 1,586 | 1,983 |
Reference price 2 | 108.0 | 113.8 |
Announcement Date | 4/28/22 | 4/8/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales 1 | 29.24 | 33.05 | 20.71 |
EBITDA 1 | 3.718 | 1.457 | -4.102 |
EBIT 1 | 2.195 | -0.6396 | -8.267 |
Operating Margin | 7.51% | -1.94% | -39.91% |
Earnings before Tax (EBT) 1 | 2.233 | 0.2811 | -8.741 |
Net income 1 | 1.776 | 0.4749 | -7.031 |
Net margin | 6.07% | 1.44% | -33.94% |
EPS 2 | 1.267 | 0.2994 | -3.550 |
Free Cash Flow | - | -11.97 | -15.69 |
FCF margin | - | -36.23% | -75.72% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 4/28/22 | 4/28/22 | 4/8/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | - | - | - |
Net Cash position 1 | 2.53 | 6.56 | 23.2 |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | -12 | -15.7 |
ROE (net income / shareholders' equity) | - | 3.74% | -21.1% |
ROA (Net income/ Total Assets) | - | -1.04% | -8.42% |
Assets 1 | - | -45.54 | 83.47 |
Book Value Per Share 2 | 5.140 | 11.50 | 24.40 |
Cash Flow per Share 2 | 4.540 | 7.480 | 13.20 |
Capex 1 | 7.08 | 8.18 | 11.7 |
Capex / Sales | 24.2% | 24.75% | 56.58% |
Announcement Date | 4/28/22 | 4/28/22 | 4/8/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+5.00% | 123M | |
-1.54% | 3.52B | |
-7.33% | 918M | |
-60.00% | 409M | |
+34.75% | 322M | |
-.--% | 116M |
- Stock Market
- Equities
- CRI Stock
- Financials Creotech Instruments S.A.